Followers | 80 |
Posts | 5335 |
Boards Moderated | 0 |
Alias Born | 11/18/2013 |
Monday, October 30, 2023 1:30:00 PM
Recent AVTX News
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 08/06/2024 04:15:06 AM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 08/05/2024 08:36:25 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/30/2024 08:01:41 PM
- Form S-3/A - Registration statement under Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 07/29/2024 08:08:55 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/16/2024 08:23:55 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 07/16/2024 08:17:53 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/16/2024 11:36:46 AM
- Avalo Therapeutics Announces Appointment of Dr. Mittie Doyle as Chief Medical Officer • GlobeNewswire Inc. • 07/16/2024 11:00:00 AM
- Form S-3/A - Registration statement under Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 07/11/2024 08:24:12 PM
- Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend] • Edgar (US Regulatory) • 07/11/2024 08:12:56 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/09/2024 11:17:21 AM
- Avalo Therapeutics Announces Appointment of Paul Varki as Chief Legal Officer • GlobeNewswire Inc. • 06/24/2024 08:01:00 PM
- Avalo to Present at the Oppenheimer Novel Targets in Immunology Summit • GlobeNewswire Inc. • 06/17/2024 11:30:00 AM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 06/07/2024 11:01:10 AM
- Form S-3 - Registration statement under Securities Act of 1933 • Edgar (US Regulatory) • 06/06/2024 08:03:22 PM
- Form 8-K/A - Current report: [Amend] • Edgar (US Regulatory) • 06/03/2024 11:20:28 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/23/2024 08:01:22 PM
- Form SC 13G - Statement of acquisition of beneficial ownership by individuals • Edgar (US Regulatory) • 05/13/2024 04:38:48 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/13/2024 11:33:15 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/13/2024 11:30:59 AM
- Avalo Reports First Quarter 2024 Financial Results and Provides Business Updates • GlobeNewswire Inc. • 05/13/2024 11:30:00 AM
- Avalo Therapeutics Appoints Biotech Leaders to Board of Directors • GlobeNewswire Inc. • 04/02/2024 11:00:00 AM
- Avalo Reports 2023 Financial Results and Provides Business Updates • GlobeNewswire Inc. • 03/29/2024 08:01:00 PM
- Avalo Acquires Anti-IL-1β mAb and Announces Private Placement Financing of up to $185 Million • GlobeNewswire Inc. • 03/27/2024 08:01:00 PM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/15/2024 02:13:42 AM
Kona Gold Beverage Inc. Signs Letter of Intent with Bemax, Inc. to Sell Kona Gold, LLC • BMXC • Aug 7, 2024 10:00 AM
Btab Ecommerce Group, Inc. Launches Investor Connect AI Chatbot for Enhanced Investor Engagement and Lead Generation • BBTT • Aug 7, 2024 9:00 AM
Hydromer, Inc. Announces Preliminary Unaudited Second Quarter 2024 Financial Results and Provides Business Update • HYDI • Aug 7, 2024 8:52 AM
North Bay Resources Announces Mt. Vernon Gold Mine Startup, Sierra County, California • NBRI • Aug 5, 2024 9:00 AM
Fifty 1 Labs, Inc. and All-In-Extracts Announce Joint Venture to Develop and Release New Testosterone Boosting Supplement • BLEG • Aug 5, 2024 8:30 AM
Kona Gold Beverages, Inc. Announces Strategic Initiatives and Corporate Direction Changes • KGKG • Aug 2, 2024 2:00 PM